Lomitapide Effective in Lowering LDL Cholesterol in Children with Homozygous Familial Hypercholesterolemia: APH-19 Study Medha Baranwal1 Nov 2024 9:00 AM ISTSpain: A recent phase 3 study, published in The Lancet Diabetes & Endocrinology, has demonstrated the effectiveness of Lomitapide in treating...
Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings MD Brand Connect30 Oct 2024 10:00 AM ISTBringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this...
Older Adults with Diabetes: Relaxed Glycemic Control Shows Unexpectedly Low Infection Risks, Study Reveals Medha Baranwal30 Oct 2024 8:45 AM ISTUSA: Recent findings shed light on the relationship between glycemic control and infection risks in older adults with type 2 diabetes (T2D).A study...
People with type 2 diabetes who eat low-carb may be able to discontinue medication, finds research Dr. Kamal Kant Kohli30 Oct 2024 8:30 AM ISTAdults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease...
Use of GLP-1 Drugs to Treat Obesity Doubled: Researchers Reveal Dr. Bhumika Maikhuri30 Oct 2024 8:30 AM ISTA new study by researchers at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, in collaboration with...
Oral Semaglutide Improves liver steatosis and injury in Diabetes Patients with MASLD, suggests study Jacinthlyn Sylvia29 Oct 2024 8:45 AM ISTA recent study highlights the potential benefits of oral semaglutide in managing type 2 diabetes mellitus (T2DM) for patients with metabolic...
Study Unveils the Role of Feeding Practices in Infant's Rapid Weight Gain Dr. Bhumika Maikhuri29 Oct 2024 8:15 AM ISTA UNC Greensboro (UNCG) study following 299 women and their infants from pregnancy to toddlerhood examined multiple psychological, biological, and...
Once-Weekly Semaglutide Cuts Heart Failure Risk in Diabetes and Kidney Disease: FLOW Trial Analysis Medha Baranwal29 Oct 2024 8:00 AM ISTUSA: In a significant advancement for cardiovascular care, the FLOW trial has demonstrated that semaglutide, a glucagon-like peptide-1 receptor...
Lowering Risk of Alzheimer's in Diabetes Patients? Semaglutide May Help, Study Suggests Dr. Bhumika Maikhuri29 Oct 2024 8:00 AM ISTResearchers at the Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular...
Complex Interplay Between T2D and MASH: Key Drivers and Emerging Treatment Strategies Dr.Niharika Harsha B28 Oct 2024 9:00 AM ISTA recent study suggested that metabolic-associated steatohepatitis can be managed by a multifaceted approach that includes diabetes-related ...
Increased risk of new-onset diabetes observed in children following COVID-19 infection: Study Jacinthlyn Sylvia28 Oct 2024 8:15 AM ISTA new study published in the Journal of American Medical Association found that children and adolescents aged 10 to 19 who were diagnosed with...
Salivary Glycated Albumin simple and reliable method for evaluating glycemic control, suggests study Medha Baranwal26 Oct 2024 8:00 AM ISTJapan: Recent research published in Diabetes Research and Clinical Practice suggests that salivary glycated albumin (GA) may serve as a reliable...
